Nexium (esomeprazole) is the first proton pump inhibitor approved for "on-demand" use

July 2007

Nexium (esomeprazole) is the first proton pump inhibitor approved for "on-demand" use in Canada.

Patients on long-term proton pump inhibitors (PPIs) take their prescribed dose less than 50% of the time. They prefer taking them PRN...it costs less and is effective in well-controlled GERD patients.

These are patients who have already received 2 to 4 weeks of a DAILY proton pump inhibitor for heartburn and/or acid reflux...and who don't have erosive esophagitis.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Is Avandia a flawed drug, or was the big new study flawed
Supplements Canadian Cancer Society upped their vitamin D recommendations
Oral Health What should you put in "magic mouthwash"
how to manage high-altitude illnesses
Infectious Diseases new oral antifungal called Spriafil
Infectious Diseases patients asking about drug-resistant tuberculosis
Infectious Diseases antibiotic prophylaxis for patients with prosthetic joints
Travel Medicine additional precautions for patients travelling while they are immunocompromised
Gastroenterology Nexium (esomeprazole) is the first proton pump inhibitor approved for "on-demand" use
Lyme Disease New guidelines will influence the treatment of Lyme disease
Obesity & Weight Loss Alli, (AL-eye), the new OTC orlistat for weight loss
long-acting naproxen called Naprelan

Nexium (esomeprazole) is the first proton pump inhibitor approved for "on-demand" use

Practical advice for a better career, with unlimited access to CE

Table of Contents